MET and hepatocellular carcinoma: We previously noted the important influence of c-Met on lenvatinib resistance, commenting on the fact that miR-128-3p, which is downregulated in lenvatinib-resistant HCC cells, exerts the most vigorous negative regulation of c-Met [162].